Criteria for Alzheimer's disease and the nosology of dementia with Lewy bodies

Neurology

Volumn 48, Issue 1, 1997, Pages 126-132

  Hansen, Lawrence A ^a,b,c   Samuel, William ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN STEM; DEMENTIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEWY BODY; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NOMENCLATURE; PRIORITY JOURNAL; SENILE PLAQUE;

EID: 0031035211     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.1.126     Document Type: Article

References (35)

1. Hansen L, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer's disease: a clinical and pathological entity. Neurology 1990;40:1-8.
2. Dickson DW. Lewy body variant. Neurology 1990;40:1147-1148.
3. Hansen L, Galasko D, Katzman R, et al. The Lewy body variant of Alzheimer's disease: a clinical and pathological entity letter. Neurology 1990;40:1148-1149.
4. Hansen LA, Masliah E, Terry RD. A neuropathological subset of Alzheimer's disease with concomitant Lewy body disease and spongiform change. Acta Neuropathol 1989;78:194-201.
5. Hansen LA, Crain BJ. Practical topics in neuropathology: making the diagnosis of mixed and non-Alzheimer's dementias. Arch Pathol Lab Med 1995;119:1023-1031.
6. Dickson DW, Davies P, Mayeux R. Diffuse Lewy body disease: neuropathological and biochemical studies of six patients. Acta Neuropathol 1987;75:8-15.
7. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK. Senile dementia of the Lewy body type: a clinical and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 1990;95:119-139.
8. Kosaka K. Diffuse Lewy body disease in Japan. J Neurol 1990; 237:197-204.
9. Joachim CL, Morris JH, Selkoe DJ. Clinically diagnosed AD: autopsy results in 150 cases. Ann Neurol 1988;24:50-56.
10. Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer's disease. Arch Pathol Lab Med 1993;117:132-144.
11. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-1105.
12. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
13. Blessed G, Tominson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968; 114:797-811.
14. Fuld PA. Psychological testing in the differential diagnosis of dementia. In: Katzman R, Terry RD, Bick KL, eds. Alzheimer's disease: senile dementia and related disorders. New York: Raven Press, 1978;185-193.
15. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state:" a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975;12:189-198.
16. Mattis S. Mental status examination for organic mental syndrome in the elderly patients: In: Bellack L, Karasu TB, eds. Geriatric psychiatry. New York: Grune and Stratton, 1976; 77-121.
17. Samuel W, Galasko D, Masliah E, et al. Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease. J Neuropathol Exp Neurol 1996;55: 44-52.
18. McKeith IG, Glasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
19. Hansen L, Masliah E, Galasko D, et al. Plaque only AD is usually the Lewy body variant, and vice versa. J Neuropathol Exp Neurol 1993;52:648-654.
20. Dickson DW, Crystal HA, Mattiace LA, et al. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 1992;13:179-189.
21. Hansen LA, Masliah E, Quijada-Fawcett S, et al. Entorhinal neurofibrillary tangles in Alzheimer's disease with Lewy bodies. Neurosci Lett 1991;129:269-272.
22. Ince P, Irving D, MacArthur F, Perry RH. Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients. J Neurol Sci 1991;106:142-152.
23. Hansen LA, Galasko D, Samuel W, et al. T. Apolipoprotein-E ∈-4 is associated with increased neurofibrillary pathology in the Lewy body variant of AD. Neurosci Lett 1994;182:63-65.
24. Morris JC, Storandt M, McKeel DW Jr, et al. Cerebral amyloid deposition and diffuse plaques in "normal" aging: evidence for presymptomatic and very mild Alzheimer's disease. Neurology 1996;46:707-719.
25. Strittmatter WJ, Saunders AM, Schmechel D. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial AD. Proc Natl Acad Sci USA 1993;90:1977-1981.
26. Galasko D, Saitoh T, Xia Y. The apolipoprotein E allele ∈4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1994;44:1950-1953.
27. Nalbantoglu J, Gilfix BM, Bertrand P, et al. Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies. Ann Neurol 1994;36:889-895.
28. Gearing M, Schneider JA, Rebeck GW, et al. Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropathologic correlates. Neurology 1995;45:1985-1990.
29. Bergeron C, Pollanen M. Lewy bodies in AD: one or two diseases? Alzheimer Dis Assoc Disord 1989;3:197-204.
30. Bierer LM, Perl DP, Haroutunian V. Neurofibrillary tangles, Alzheimer's disease, and Lewy bodies. Lancet 1990;335:8682.
31. Ditter SM, Mirra SS. Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients. Neurology 1987;37:754-760.
32. Harrington CR, Louwagie J, Rossau R. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Am J Pathol 1994;145:1472-1484.
33. Pickering-Brown SM, Mann DMA, Bourke JP, et al. Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other beta amyloid forming diseases [letter]. Lancet 1994;343:1115.
34. Huelette C, Mirra S, Wilkinson W, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). IX. A prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease. Neurology 1995;45:1991-1995.
35. Strong C, Anderton BH, Perry RH, et al. Abnormally phosphorylated tau protein in senile dementia of the Lewy body type and Alzheimer's disease: evidence that the disorders are distinct. Alzheimer Dis Assoc Disord 1995;9:218-222.